ArticleNature2024
Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer.
Abstract readPublished Erratum
In one paragraph
Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PTEN Oxidation Promotes Constitutive PI3K Signaling and Inducible Macropinocytosis in Pancreatic Cancer.Cancer research · 2026Article
Corrections and comments
- Erratum for
Authors and funding
66 authors.
Urszula N Wasko *Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Jingjing Jiang *Revolution Medicines, Redwood City, CA, USA.
Tanner C DaltonDepartment of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Alvaro Curiel-GarciaDepartment of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-6249-3267
A Cole EdwardsDepartment of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Yingyun WangRevolution Medicines, Redwood City, CA, USA.
Bianca LeeRevolution Medicines, Redwood City, CA, USA.
Margo OrlenUniversity of Pennsylvania Perelman School of Medicine, Department of Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-9834-6282
Sha TianCancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Clint A StalneckerLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0002-0570-4416
Kristina Drizyte-MillerLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Marie MenardRevolution Medicines, Redwood City, CA, USA.
Julien DillyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4006-5285
Stephen A SastraDepartment of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Carmine F PalermoDepartment of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Marie C HasselluhnDepartment of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-9765-4075
Amanda R Decker-FarrellDepartment of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Stephanie ChangRevolution Medicines, Redwood City, CA, USA.ORCID http://orcid.org/0009-0000-2026-5215
Lingyan JiangRevolution Medicines, Redwood City, CA, USA.
Xing WeiRevolution Medicines, Redwood City, CA, USA.
Yu C YangRevolution Medicines, Redwood City, CA, USA.
Ciara HellandRevolution Medicines, Redwood City, CA, USA.
Haley CourtneyRevolution Medicines, Redwood City, CA, USA.
Yevgeniy GindinRevolution Medicines, Redwood City, CA, USA.
Karl MuonioRevolution Medicines, Redwood City, CA, USA.
Ruiping ZhaoRevolution Medicines, Redwood City, CA, USA.
Samantha B KempUniversity of Pennsylvania Perelman School of Medicine, Department of Medicine, Philadelphia, PA, USA.
Cynthia ClendeninUniversity of Pennsylvania Perelman School of Medicine, Abramson Cancer Center, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-4535-2088
Rina SorUniversity of Pennsylvania Perelman School of Medicine, Abramson Cancer Center, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-2042-5746
William P VostrejsUniversity of Pennsylvania Perelman School of Medicine, Department of Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-1659-0186
Priya S HibshmanDepartment of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Amber M AmparoLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0003-3805-746X
Connor HennesseyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Matthew G ReesThe Broad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-2987-7581
Melissa M RonanThe Broad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-4269-1404
Jennifer A RothThe Broad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-5117-5586
Jens BrodbeckRevolution Medicines, Redwood City, CA, USA.
Lorenzo TomassoniHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
Basil BakirDepartment of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Nicholas D SocciBioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Laura E HerringUNC Michael Hooker Proteomics Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0003-4496-7312
Natalie K BarkerUNC Michael Hooker Proteomics Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Junning WangDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
James M ClearyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Brian M WolpinDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0455-1032
John A ChabotDepartment of Surgery, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Michael D KlugerDepartment of Surgery, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Gulam A ManjiDepartment of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Kenneth Y TsaiDepartment of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.ORCID http://orcid.org/0000-0001-5325-212X
Miroslav SekulicDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA.
Stephen M LaganaDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA.
Andrea CalifanoDepartment of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Elsa QuintanaRevolution Medicines, Redwood City, CA, USA.
Zhengping WangRevolution Medicines, Redwood City, CA, USA.
Jacqueline A M SmithRevolution Medicines, Redwood City, CA, USA.ORCID http://orcid.org/0000-0001-5028-8725
Matthew HolderfieldRevolution Medicines, Redwood City, CA, USA.
David WildesRevolution Medicines, Redwood City, CA, USA.ORCID http://orcid.org/0009-0009-3855-7270
Scott W LoweCancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-5284-9650
Michael A BadgleyDepartment of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Andrew J AguirreDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0701-6203
Robert H VonderheideUniversity of Pennsylvania Perelman School of Medicine, Department of Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-7252-954X
Ben Z StangerUniversity of Pennsylvania Perelman School of Medicine, Department of Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-0410-4037
Timour BaslanDepartment of Biomedical Sciences, School of Veterinary Medicine, The University of Pennsylvania, Philadelphia, PA, USA.
Channing J DerLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0002-7751-2747
Mallika SinghRevolution Medicines, Redwood City, CA, USA. msingh@revmed.com.
Kenneth P OliveDepartment of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA. kenolive@columbia.edu.ORCID http://orcid.org/0000-0002-3392-8994
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.